{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:36:12Z","timestamp":1785173772802,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA167079"],"award-info":[{"award-number":["CA167079"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM145773"],"award-info":[{"award-number":["T32GM145773"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.mcpro.2025.101043","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T15:11:54Z","timestamp":1753369914000},"page":"101043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Proteomic Analysis of Hsp90\u03b2-Selective Inhibitors Against Triple-Negative Breast Cancer to Gain a Mechanistic Insight"],"prefix":"10.1016","volume":"24","author":[{"given":"Tyelor S.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1903-6516","authenticated-orcid":false,"given":"Daniel D.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4354-0309","authenticated-orcid":false,"given":"Simon D.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0475-8540","authenticated-orcid":false,"given":"Emma C.","family":"Ronck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket J.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5927-5277","authenticated-orcid":false,"given":"Matthew M.","family":"Champion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6200-3480","authenticated-orcid":false,"given":"Brian S.J.","family":"Blagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcpro.2025.101043_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2025.101043_bib2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrm3658","article-title":"Chaperone machines for protein folding, unfolding and disaggregation","volume":"14","author":"Saibil","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mcpro.2025.101043_bib3","doi-asserted-by":"crossref","first-page":"117713","DOI":"10.1016\/j.ejmech.2025.117713","article-title":"Glucose-regulated protein 94 (Grp94\/gp96) in viral pathogenesis: insights into its role and therapeutic potentials","volume":"292","author":"Xu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.mcpro.2025.101043_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/acsomega.4c06661","article-title":"Conformationally restricted grp94-selective inhibitors","volume":"10","author":"Xu","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.mcpro.2025.101043_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cstres.2024.05.005","article-title":"An update on the status of HSP90 inhibitors in cancer clinical trials","volume":"29","author":"Rastogi","year":"2024","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.mcpro.2025.101043_bib6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tibs.2010.02.005","article-title":"HSP90 manages the ends","volume":"35","author":"DeZwaan","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.mcpro.2025.101043_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.101043_bib8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1021\/acsmedchemlett.7b00193","article-title":"Resorcinol-based Grp94-selective inhibitors","volume":"8","author":"Khandelwal","year":"2017","journal-title":"Acs Med. Chem. Lett."},{"key":"10.1016\/j.mcpro.2025.101043_bib9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1021\/acs.jmedchem.0c01700","article-title":"The development of Hsp90 beta-selective inhibitors to overcome detriments associated with pan-Hsp90 inhibition","volume":"64","author":"Mishra","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mcpro.2025.101043_bib10","doi-asserted-by":"crossref","first-page":"10547","DOI":"10.1002\/anie.202015422","article-title":"Selective inhibition of the Hsp90 alpha isoform","volume":"60","author":"Mishra","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.mcpro.2025.101043_bib11","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1021\/acsmedchemlett.2c00327","article-title":"Structure-activity relationship study of tertiary alcohol Hsp90?-selective inhibitors with novel binding mode","volume":"13","author":"Mishra","year":"2022","journal-title":"Acs Med. Chem. Lett."},{"key":"10.1016\/j.mcpro.2025.101043_bib12","doi-asserted-by":"crossref","first-page":"0223","DOI":"10.1016\/j.ejmech.2023.115531","article-title":"Elucidation of novel TRAP1-Selective inhibitors that regulate mitochondrial processes","volume":"258","author":"Merfeld","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.mcpro.2025.101043_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116736","article-title":"Extracellular heat shock protein 90 alpha (eHsp90\u03b1)'s role in cancer progression and the development of therapeutic strategies","volume":"277","author":"Reynolds","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.mcpro.2025.101043_bib14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mcpro.2025.101043_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2015.06.018","article-title":"Regulation and function of the human HSP90AA1 gene","volume":"570","author":"Zuehlke","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.mcpro.2025.101043_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/dev.127.1.1","article-title":"Mice lacking HSP90 beta fail to develop a placental labyrinth","volume":"127","author":"Voss","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.mcpro.2025.101043_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/cells12020277","article-title":"The distinct assignments for Hsp90\u03b1 and Hsp90\u03b2: more than skin deep","volume":"12","author":"Chang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.mcpro.2025.101043_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1242\/bio.2012646","article-title":"Spermatogenesis arrest caused by conditional deletion of Hsp90 alpha in adult mice","volume":"1","author":"Kajiwara","year":"2012","journal-title":"Biol. Open"},{"key":"10.1016\/j.mcpro.2025.101043_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01913","article-title":"A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors","volume":"425","author":"Kamal","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2025.101043_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00280-004-0865-3","article-title":"Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts","volume":"55","author":"Eiseman","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.mcpro.2025.101043_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.chembiol.2004.04.008","article-title":"Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90","volume":"11","author":"Vilenchik","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.mcpro.2025.101043_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02013-1","article-title":"Structure-guided design of an Hsp90 beta N-terminal isoform-selective inhibitor","volume":"9","author":"Khandelwal","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.101043_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1005045","article-title":"Hsp90 beta inhibition upregulates interferon response and enhances immune checkpoint blockade therapy in murine tumors","volume":"13","author":"Rahmy","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcpro.2025.101043_bib24","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.014654","article-title":"Quantitative proteomics reveals that Hsp90 inhibition preferentially targets kinases and the DNA damage response","volume":"11","author":"Sharma","year":"2012","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.mcpro.2025.101043_bib25","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.016675","article-title":"Systematic identification of the HSP90 candidate regulated proteome","volume":"11","author":"Wu","year":"2012","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.mcpro.2025.101043_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jprot.2015.02.020","article-title":"Hsp90 inhibition induces both protein-specific and global changes in the ubiquitinome","volume":"120","author":"Quadroni","year":"2015","journal-title":"J. Proteomics"},{"key":"10.1016\/j.mcpro.2025.101043_bib27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/14789450.2017.1389649","article-title":"Proteomic interrogation of HSP90 and insights for medical research","volume":"14","author":"Weidenauer","year":"2017","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.mcpro.2025.101043_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/genetics\/iyae057","article-title":"Quantitative proteomic analysis reveals unique Hsp90 cycle-dependent client interactions","volume":"227","author":"Rios","year":"2024","journal-title":"Genetics"},{"key":"10.1016\/j.mcpro.2025.101043_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100560","article-title":"Investigation of cellular response to the HSP90 inhibition in human cells through thermal proteome profiling","volume":"22","author":"Yin","year":"2023","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.mcpro.2025.101043_bib30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s12192-009-0115-z","article-title":"Novel Hsp90 partners discovered using complementary proteomic approaches","volume":"14","author":"Tsaytler","year":"2009","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.mcpro.2025.101043_bib31","article-title":"N-terminal proteomics of","volume":"13","author":"Hu","year":"2024","journal-title":"Microbiol. Resour. Announc."},{"key":"10.1016\/j.mcpro.2025.101043_bib32","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1039\/D2AY01549H","article-title":"Miniprep assisted proteomics (MAP) for rapid proteomics sample preparation","volume":"15","author":"Mousseau","year":"2023","journal-title":"Anal Methods"},{"key":"10.1016\/j.mcpro.2025.101043_bib33","series-title":"QFeatures: Quantitative features for mass spectrometry data","author":"Gatto","year":"2023"},{"key":"10.1016\/j.mcpro.2025.101043_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2025.101043_bib35","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.12688\/f1000research.139116.1","article-title":"A Bioconductor workflow for processing, evaluating, and interpreting expression proteomics data","volume":"12","author":"Hutchings","year":"2023","journal-title":"F1000Res"},{"key":"10.1016\/j.mcpro.2025.101043_bib36","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"10.1016\/j.mcpro.2025.101043_bib37","article-title":"How to obtain the confidence interval from a P value","volume":"343","author":"Altman","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.mcpro.2025.101043_bib39","series-title":"Integrated Development Environment for R. Posit Software","year":"2023"},{"key":"10.1016\/j.mcpro.2025.101043_bib40","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.mcpro.2025.101043_bib41","author":"Chen"},{"key":"10.1016\/j.mcpro.2025.101043_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pro.3978","article-title":"The BioGRID database: a comprehensive biomedical resource of curated protein, genetic, and chemical interactions","volume":"30","author":"Oughtred","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.mcpro.2025.101043_bib43","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2025.101043_bib44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mcpro.2025.101043_bib45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.mcpro.2025.101043_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12859-016-1433-7","article-title":"KinMap: a web-based tool for interactive navigation through human kinome data","volume":"18","author":"Eid","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.mcpro.2025.101043_bib47","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2025.101043_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2023.102383","article-title":"Dissecting the functional significance of HSP90AB1 and other heat shock proteins in countering glioblastomas and ependymomas using omics analysis and drug prediction using virtual screening","volume":"102","author":"Sharma","year":"2023","journal-title":"Neuropeptides"},{"key":"10.1016\/j.mcpro.2025.101043_bib49","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1172\/JCI125963","article-title":"Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation","volume":"129","author":"Pan","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mcpro.2025.101043_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120852","article-title":"Molecular chaperones in DNA repair mechanisms: role in genomic instability and proteostasis in cancer","volume":"306","author":"Hasan","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.mcpro.2025.101043_bib51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/bs.acr.2015.09.003","article-title":"Hsp90 as a \"chaperone\" of the epigenome: insights and opportunities for cancer therapy","volume":"129","author":"Isaacs","year":"2016","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.mcpro.2025.101043_bib52","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/acs.jproteome.3c00379","article-title":"CDK1-SRC interaction-dependent transcriptional activation of HSP90AB1 promotes antitumor immunity in hepatocellular carcinoma","volume":"22","author":"Zhang","year":"2023","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcpro.2025.101043_bib53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.gene.2015.08.063","article-title":"HSP90AB1: helping the good and the bad","volume":"575","author":"Haase","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.mcpro.2025.101043_bib54","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1074\/jbc.272.17.11648","article-title":"Hsp90 is obligatory for the heme-regulated eIF-2alpha kinase to acquire and maintain an activable conformation","volume":"272","author":"Uma","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2025.101043_bib55","doi-asserted-by":"crossref","first-page":"48846","DOI":"10.1074\/jbc.M407687200","article-title":"Hsp90 regulates the activity of wild type p53 under physiological and elevated temperatures","volume":"279","author":"M\u00fcller","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2025.101043_bib56","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/sj.cr.7310109","article-title":"Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK)","volume":"16","author":"Qing","year":"2006","journal-title":"Cell Res."},{"key":"10.1016\/j.mcpro.2025.101043_bib57","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00109-004-0549-9","article-title":"Targeting multiple signal transduction pathways through inhibition of Hsp90","volume":"82","author":"Zhang","year":"2004","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.mcpro.2025.101043_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.virs.2023.11.008","article-title":"Hsp90 \u03b2 is critical for the infection of severe fever with thrombocytopenia syndrome virus","volume":"39","author":"Wang","year":"2024","journal-title":"Virol. Sin."},{"key":"10.1016\/j.mcpro.2025.101043_bib59","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1042\/CBI20120274","article-title":"Expression of cyclin A, B1 and D1 after induction of cell cycle arrest in the Jurkat cell line exposed to doxorubicin","volume":"36","author":"Zury\u0144","year":"2012","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.mcpro.2025.101043_bib60","article-title":"The role of CRYAB in tumor prognosis and immune infiltration: a Pan-cancer analysis","volume":"9","author":"Cheng","year":"2022","journal-title":"Front Surg."},{"key":"10.1016\/j.mcpro.2025.101043_bib61","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3724\/abbs.2024059","article-title":"PACSIN1 promotes immunosuppression in gastric cancer by degrading MHC-I","volume":"56","author":"Liu","year":"2024","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"key":"10.1016\/j.mcpro.2025.101043_bib62","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2174\/1871520620666200203125712","article-title":"CDK1 in breast cancer: implications for theranostic potential","volume":"20","author":"Izadi","year":"2020","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.mcpro.2025.101043_bib63","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1073\/pnas.0903392106","article-title":"Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models","volume":"106","author":"Caldas-Lopes","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.101043_bib64","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cancergen.2018.10.003","article-title":"Identification and characterization of a novel nuclear structure containing members of the homologous recombination and DNA damage response pathways","volume":"228-229","author":"Sierant","year":"2018","journal-title":"Cancer Genet."},{"key":"10.1016\/j.mcpro.2025.101043_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1488137","article-title":"MyD88 signaling pathways: role in breast cancer","volume":"14","author":"Zheng","year":"2024","journal-title":"Front Oncol."},{"key":"10.1016\/j.mcpro.2025.101043_bib66","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200869","article-title":"Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis","volume":"41","author":"Lin","year":"2021","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.mcpro.2025.101043_bib67","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cell.2012.06.047","article-title":"Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition","volume":"150","author":"Taipale","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.101043_bib68","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1016\/j.febslet.2005.10.020","article-title":"A proteomic snapshot of the human heat shock protein 90 interactome","volume":"579","author":"Falsone","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mcpro.2025.101043_bib69","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41585-022-00571-8","article-title":"Therapeutic potential of CDK4\/6 inhibitors in renal cell carcinoma","volume":"19","author":"Sager","year":"2022","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.mcpro.2025.101043_bib70","first-page":"11","article-title":"Design of disruptors of the Hsp90-Cdc37 Interface","volume":"25","author":"D'Annessa","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.mcpro.2025.101043_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/mcb.00459-21","article-title":"Heterogeneous responses and isoform compensation dim the therapeutic window of Hsp90 ATP-binding inhibitors in cancer","volume":"42","author":"Tang","year":"2022","journal-title":"Mol. Cell Biol."}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947625001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947625001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:26:00Z","timestamp":1778617560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947625001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1535947625001422"],"URL":"https:\/\/doi.org\/10.1016\/j.mcpro.2025.101043","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomic Analysis of Hsp90\u03b2-Selective Inhibitors Against Triple-Negative Breast Cancer to Gain a Mechanistic Insight","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcpro.2025.101043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101043"}}